The results of the analysis performed will allow to optimize the purchase of drugs in accordance with the structure of diseases registered in the given healthcare institution, as well as the structure of the local formulary.
One of the main tasks of healthcare of any country is providing medical care of the adequate quality. According to experts of the World Health Organization, any country in the world does not have sufficient resources to healthcare. Even countries with high economic growth have to look for mechanisms to optimize the use of health budgets. In recent years particularly acute this problem arose in Ukraine.
The experience of a number of economically developed countries allows to note a significant role, which can be played by introduction of the formulary system based on the standards of treatment and the principles of evidence-based medicine in solving these problems. Introduction of the formulary system is the most effective means of economical use of budgetary funds allocated for the drug supply [3, 10, 11, 13, 14] .
An important element of the quality management system providing availability, effectiveness and safety of drugs is conducting the ABC/VEN-analysis by healthcare institutions on using budgetary funds for the drug supply. To implement this task according to the requirements of the order of the Ministry of Public Health of Ukraine dated 22. 07. 2009 No. 529 "About creating a formulary system for the drug supply of healthcare institutions" the pharmacotherapeutic commission (PTC) is created by the order of the chief physician of a healthcare institution. An important task of such commission together with development and constant updating of the local formulary of drugs is providing physicians with information on the rational pharmacotherapy, as well as conducting the ABC-, VEN-analysis on using drugs, determination of rationality of their purchase in accordance with the priorities of pharmacotherapy of diseases registered in healthcare institutions (statistical data form No.20) [4, 5, 14] .
Conducting of the clinical and economic analysis is the most time consuming chain in the process of introduction of the formulary system. Despite the obvious perspective and the rapid development of this direction of research, its effectiveness is still rather low. One of the causes admitted by researchers is the lack of awareness of physicians concerning the issues of pharmacoeconomics and conservatism in prescribing drugs that is probably associated with this. Existing practical methods and guidelines are largely limited. For example, the ABC/VEN-analysis is mostly conducted by researchers while studying the system of using drugs for a certain nosological form of the disease, or separate groups of drugs, and it makes its implementation in practical work of healthcare institutions is quite time-consuming and insufficiently informative. When forming the local formulary there is virtually no experience in assessing the drug utility that would allow PTC to estimate objectively the degree of provision of patients with drugs, as well as the correspondence of the financial costs to the structure of diseases registered in the given healthcare institution [1, 2, 3, 8, 9] .
The lack of specialists with the knowledge in the fields of economics, healthcare and pharmacy in most healthcare institutions, as well as computer technologies determine the need of development of the corresponding methodological recommendations [5, 6] .
With introduction of the formulary system, in particular, creation of local formularies of drugs in healthcare institutions, and necessity of regular conducting of the ABC/VEN-analysis, the members of PTC must master the method of its conducting with the use of computer technologies.
Based on the above the aim of our study was to practice the method of the integrated ABC/VEN-analysis of using drugs when forming and updating local formularies, as well as determination of rationality of their purchase and the correspondence to the structure of the patients admitted to hospital.
Materials and Methods
For the retrospective assessment of the rational use of the budgetary funds of a certain healthcare institution to purchase drugs such method of clinico-economic analysis as the АВС/VEN-analysis is used. Combination of the АВС and VEN analysis gives an idea about what drugs that are vital (V), essential (Е); nonessential (N) take the most significant place in the structure of expenses of the healthcare institution for the drug supply.
The АВС-analysis (the Pareto principle) is a standard method used in the world when assessing current expenditures for purchase of drugs and their planning for the next year under the conditions of introduction of the formulary system.
The current modification of the VEN-analysis is assessment of the drug utility, i.e. degree of the need to use the given drug for pharmacotherapy of a specific disease, and it is extremely important, in particular, when deciding the reasonability of including the corresponding drug to the local formulary of the healthcare institution [1, 7] .
In this case it is possible to determine the level of utility in the form of specific indexes VEN (UV, UE, UN) adding the code of a disease to them according to ICD-10. For example, according to the standardized protocol of medical care approved by the order of the Ministry of Public Health of Ukraine dated 19.03.07 No. 128 "On approval of clinical protocols of medical care in the specialty "Pulmonology" in drug therapy of community-acquired pneumonia (ICD-10 code -J15.9) the solution for infusion "Leflocin" will have the index of utility UV J15.9. This index can be further objectify if the level of efficiency and safety of drugs is added to it on the scale of levels of evidence. The index "0" refers to the utility of the drug, which is absent in clinical protocols of medical care of diseases registered in the given healthcare institution in the current State formulary of drugs, or in the List of Drugs that can be purchased by healthcare institutions fully or partially financed from the budget [12] .
The benefits of implementing such analysis is obvious since it closely links the structure of morbidity registered in the healthcare institution (ICD-10 code), the corresponding protocols of medical care and drugs used in the drug therapy.
By definition, a local formulary should contain as many drugs as possible, which in relation to diseases registered in the particular healthcare institution must be referred to vital and essential drugs, and, therefore, have the index of utility (U V) and (U E ), and only in extreme cases -to nonessential drugs (U N ).
It should be noted that at the beginning of the study (2012) the most common approach to development of the local formulary was as follows: all drugs used at that moment in the healthcare institution were considered a basic formulary, which in the future should gradually be updated and improved according to the principles of the formulary system. That is, based on the results obtained, PTC of the healthcare institution planned to develop pharmacoeconomically reasonable local formularies that would have to meet the requirements of normative legal documents. An important role in this process was given to the ABC/VEN-analysis [11] .
In our research 398 healthcare institutions of the secondary and tertiary levels from the Dnipropetrovsk, Vinnytsia, Kharkiv, Kyiv and other regions of Ukraine took part, they developed their local formularies (LF) for 2013 based on the current of the fifth edition of the State formulary (SF). In order to update and improve LF for 2014 the ABC/VEN-analysis of the rational use of budgetary funds for the purchase of drugs was conducted upon completion of the period under review together with PTC of these healthcare institutions, and the appropriate recommendations concerning improvement of the structure of their purchase, as well as optimization of the content of LF were given.
To improve clarity of the process of conducting the integrated ABC/VEN-analysis with the use of computer technologies we consider it expedient to comment it on the example of one of the healthcare institutions in the Dnipropetrovsk region. The basic data are that in 2013 the healthcare institution spent the budgetary funds in the amount of 468371,66 UAH for purchasing 106 names of drugs (data from the local formulary and accounting documents).
The structure of diseases registered in the healthcare institution (statistical data form No.20 for 2013) according to ICD-10 codes is as follows: A00, A08, А04.9, G45, G90-99, І10-13, I20-25, I60, I63, I69, I69.4, I70.8, I177.6, I178, J-00-99, J00-J06, J15.9, J18, J45, K00-K93, K26, K29, K30, К35.9, К 80, K81, K82, K85, K86, L00-L08, L50, М16-19, М42, М54, N 20, N30, R52.0, T36-50, T51, T79.4, Т-98, etc.
All trade names of drugs purchased by the healthcare institution within a year were introduced indicating their amount and cost of purchase to the computer in a spreadsheet format with the help of Microsoft Office Excel programme. From the local formulary the data regarding the category of vital importance -V, E, N assigned to each trade name of the drug purchased for the budgetary funds were introduced (Fig.) .
With the help of spreadsheet functions drugs were ranked in descending order of the cost for their purchase, the total cost of drugs actually purchased in 2013 was calculated, the expense percentage of the healthcare institution per each individual drug from the sum of the total cost for drug purchase was calculated, the so-called "cumulative percentage" was determined for each drug.
It was further determined which class of АВС should include each of the drugs purchased for the budgetary funds. Drugs, which cumulative percentage was ≤80%, were referred to category А; drugs with the cumulative percentage of 80%≥95% were referred to category В; and drugs with the cumulative percentage of 95%≥100% fell in the category С. Class ABC for each drug was determined using spreadsheets.
With the help of spreadsheet functions the results of the ABC/VEN-analysis for all trade names of drugs were obtained (column 14).

Results and Discussion
The results of the ABC/VEN-analysis conducted were listed in Tab. 1 for clarity.
Then for the first time in the practice of the formulary system introduction the index of utility for the drugs purchased was determined with addition of the appropriate codes of diseases in each drug trade name registered in healthcare institutions in according to ICD-10. Ideally, certain diseases codes must correspond to all drugs used in pharmacotherapy of diseases registered in healthcare institutions and included into the local formulary.
The results of the ABC/VEN-analysis with the index of utility determined for each drug purchased for the budgetary funds were listed in Tab. 2.
According to the results of the integrated ABC/VENanalysis with determination of the level of utility of each drug the following conclusions and recommendations were made by PTC of the healthcare institution:
• Of 106 names of drugs purchased by the healthcare institution, 16 names of drugs, such as mildrocard, l-lysine aescinat, actovegin, etc., are absent in the 5-th edition of the State formulary, and therefore, it is inexpedient to classify them as vital (V) and essential (Е) drugs. The share of such drugs was 68.66% of the total expenditures; • The approaches to the use of drugs of the vital (V) category, which should be given priority when purchasing, should be revised. 83 Drugs were referred to this category, their share in the total budget expenditures was 86.03%. Among them 12 names of drugs (61.20%) are absent in the current State formulary; it is no reason to assign 29 names of drugs (9.44%), such as pentoxifylline, sermion, mucolvan, asparcam, etc., to the category (V).
• The approaches to the use of drugs of the essential drug category (Е) should be revised. "On approval of the sixth edition of the State formulary of drugs and providing its availability", and considering the comments received regarding the structure of the drug purchase in 2013, the PTC of healthcare institutions participating in the research made the appropriate changes to the plan of purchasing drugs for budgetary funds for 2014, as well as revised the content of the current local formularies with the purpose of correcting the LF project and the plan of the drug purchase for 2015. The results of the integrated ABC/VEN-analysis of planned indicators of the drug purchase in 2015 indicate qualitative positive changes in the structure of purchasing of categories (V) and (E), as well as in assessing the utility of drugs included to the local formulary.
Summarizing the results of the integrated ABC/VENanalysis conducted by us with the participation of PTC of healthcare institutions according to the results of drug purchasing in 2013 a number of disadvantages that are common practically for all healthcare institutions may be noted in the process of the local formularies updating and purchasing drugs for budgetary funds.
Obvious signs of irrational use of budgetary funds are as follows:
• the presence of drugs categorized to N (AN) in class A, but they should not be in this class; • insufficient presence of drugs of V (AV) category in class A, which should be used for treating diseases with a significant specific weight in the structure of diseases registered in healthcare institutions; • the index of utility of some drugs equals "0"; it indicates the absence of the drug in the current State formulary or in unified clinical protocols of medical care for diseases registered in the given healthcare institution.
Therefore, the results of the integrated ABC/VENanalysis allow to improve the purchasing policy of essential drugs (АV; AE) under the conditions of the total budget deficit, reduce the use of ineffective drugs (AN; BN) and form an effective local formulary. CONCLUSIONS The use of ABC/VEN-analysis under the conditions of introduction of the formulary system is extremely important in order to optimize costs for the drug supply of the diagnostic and treatment process and improvement of the efficiency of pharmacotherapy. Its application in the practical work of healthcare institutions can be the real basis for determination of priorities to optimize the supply campaign.
An essential addition of the ABC/VEN-analysis that allows to assess objectively the degree of necessity of using various drugs registered in a healthcare institution for pharmacotherapy of specific diseases is assessment of its utility (U V, U E, U N ). The results of the integrated ABC/VENanalysis with determination of the level of the index of utility of each drug indicate its effectiveness to control the rational use of budgetary funds on the drug supply.
Coclusions according to the results of the integrated ABC/VEN-analysis will allow to optimize the structure of the local formulary of the healthcare institution, provide priority funding for purchasing vital drugs, prepare a substantiated request for the next period of the drug purchase, take appropriate management decisions by the healthcare institution concerning the further implementation of the formulary system principles.
The annual integrated ABC/VEN-analysis conducted by PTC with determination of the level of utility of each drug included into the local formulary allows to identify routinely the problems existing in the healthcare institution in relation to pharmacotherapy of diseases, thereby significantly increasing the level of medical care and fully implementing the medical, pharmacological, economic, professional, educational and informational functions of the formulary system. 
